Beauty Health Co 8-K

What Happened
Beauty Health Co (SKIN) filed an 8-K on March 6, 2026 reporting that on March 3, 2026 it notified stockholders of record (as of February 20, 2026) that the parties in the consolidated Delaware Court of Chancery derivative action, Elstein v. Saunders et al., C.A. No. 2024-0114-LWW, entered a Stipulation of Settlement on February 9, 2026. The settlement is subject to court approval. The company attached the required Notice of Pendency and Proposed Settlement of Derivative Action as Exhibit 99.1 to the filing.

Key Details

• Stipulation of Settlement entered: February 9, 2026; Scheduling Order entered by the Court: February 20, 2026.
• Stockholders of record date for notice: February 20, 2026; company mailed notice on March 3, 2026.
• The settlement would resolve the claims described in Note 6 of the Company’s Condensed Consolidated Financial Statements for the period ended September 30, 2025 (see Form 10-Q filed November 6, 2025).
• The Notice is filed as Exhibit 99.1 and the Stipulation and related exhibits are available on the company’s Legal Notices webpage.

Why It Matters
This filing informs investors that the company is pursuing a court-approved settlement to resolve the consolidated derivative litigation disclosed previously in its financial statements. Because the settlement is subject to Delaware Court of Chancery approval, it is not final—investors should review Note 6 of the September 30, 2025 financial statements and the attached Notice for details on the claims and any disclosed financial impact or remedies. The 8-K documents where to find the Stipulation and hearing schedule so shareholders can monitor the court process and any potential effects on the company.